Brochure Available! 2019 Drug Pricing and Reimbursement Stakeholder Summit
Thursday April 25th, 2019
I invite you to view the brochure for the 2019 Drug Pricing and Reimbursement Stakeholder Summit, taking place on July 15–16 in Philadelphia!
With unpredictable changes occurring in the drug pricing transparency landscape, it is imperative to stay ahead of legislation and trends, thus maintaining a competitive edge within the industry.
Through panels, case studies, and focused presentations, this conference will showcase how key stakeholders surrounding drug pricing matters are initiating change to accommodate for drug pricing shifts.
EXPLORE CHANGES TO THE POLICY LANDSCAPE THROUGH AN OVERVIEW OF THE MOST PREVALENT STATE TRANSPARENCY LAWS
Kendra Martello, Senior Director, Public Policy, MALLINCKRODT PHARMACEUTICALS
EXPLORE THE OPERATIONAL COMPONENT OF THE DRUG PRICING TRANSPARENCY LAWS AND DISCUSS ITS IMPLICATIONS ON DEPARTMENTAL PROCEDURES
Deborah Walters, Vice President and Assistant General Counsel, PFIZER
Keren Tenenbaum, Assistant General Counsel, PFIZER
HARNESS VALUE-BASED AGREEMENT POWER FOR MAXIMUM MULTI-STAKEHOLDER BENEFIT
John Alter, VP, Patient and Health Impact Lead, Hospital Business Unit, PFIZER
THE EFFECT OF STRATEGIC PRACTICES WITHIN HEOR UPON VALUE-BASED PRICING AND REIMBURSEMENT MATTERS
Boxiong Tang, M.D., Senior Director, Health Economics and Outcomes Research (HEOR), BEIGENE, LTD.
Click here to reserve your seat today, or book before June 7 to save $200 off the standard registration rate.
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs